Calton & Associates »

Iovance Biotherapeutics shares owned by Calton & Associates

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Calton & Associates from 13F filings

Historical chart of Calton & Associates investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Calton & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Calton & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 10k 2.17
2025-06-30 $17k 10k 1.72
2023-12-31 $98k 12k 8.13
2020-12-31 $209k 4.5k 46.44
2017-12-31 $7.0k 10 700.00

More positions owned by Calton & Associates

Invesco Qqq Tr Unit Ser 1 (QQQ)
Northern Lts Fd Tr Ii Peakshares Secto (PSTR)
Spdr Series Trust Portfolio S&p500 (SPLG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Fidelity Covington Trust High Divid Etf (FDVV)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Vanguard World Financials Etf (VFH)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Invesco Actively Managed Exc Var Rate Invt (VRIG)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Technology (XLK)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Vanguard World Mega Cap Index (MGC)

View all positions for Calton & Associates

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics